We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Crohn’s disease

News List

New analyses support the effectiveness and safety of Entyvio (vedolizumab) pharmaasia
May 31, 2017
Data showcased at Digestive Disease Week (DDW) 2017 meeting include presentations of new analyses from the VICTORY consortium.
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III S b3cnewswire
March 22, 2017
A first randomized, double-blind, placebo-controlled Phase III clinical study with RHB-104 for the treatment of Crohn’s disease (the MAP US study) is ongoing in the U.S. and additional countries.
Celltrion Healthcare’s biosimilar shows positive results in Crohn’s disease study europeanpharmaceuticalreview
February 21, 2017
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar of infliximab) in Crohn’s disease.
Enterome starts Phase I Crohn’s disease trial europeanpharmaceuticalreview
January 06, 2017
Enterome has launched a Phase I clinical study with its lead drug candidate EB8018, a small molecule designed to block FimH, as a potential new treatment for Crohn’s disease.

Previous page 1 2 Next page